WANTAI SARS-COV-2 Rapid Antigen Test (RAT) is a lateral flow immunofluorescent assay (FIA) intended for screening of high risk individuals for the COVID-19 virus, using nasopharyngeal (NP) and oropharyngeal (OP) swab specimens.
Our RAT kits are included in the Australian Register of Therapeutic Goods 345191.
Suretest was founded by Dr Peter Lewis, an internationally recognised regenerative medicine physician. As the Medical Director of Surecell, Dr Lewis treats patients, trains medical professionals from across the globe and hosts monthly public seminars at his Malvern clinic.
Contact us on 03 8547 3685 or info@suretest.com.au!
Company Details
- Address
- 1291 Malvern Road, Malvern,victoria 3144,australia
- Industry
- Medical Device
- Website
- https://www.suretest.com.au/
- Keywords
- Ellume.
- HQ
- Malvern, Victoria
Suretest Australia Questions
Suretest Australia's website is https://www.suretest.com.au/
Suretest Australia's LinkedIn profile is https://au.linkedin.com/company/suretest-australia
Suretest Australia's industry is
Medical Device
Suretest Australia's top competitors are
Inoviq Ltd (Asx:iiq),
Ellume,
Sonic Genetics,
Vccc Alliance,
Surescreen Diagnostics (Australia),
Surescreen Diagnostics,
Bloom Diagnostics,
Psc Biotech - Australia,
Suretest,
Crest Medical Ltd.
Suretest Australia's categories are Medical Device
